Cargando…

CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases

INTRODUCTION: Autoimmune/inflammatory rheumatic diseases (AIRDs) patients might be at-risk of severe COVID-19. However, whether this is linked to the disease or to its treatment is difficult to determine. This study aimed to identify factors associated with occurrence of severe COVID-19 in AIRD pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevalier, Kevin, Genin, Michaël, Jean, Thomas Petit, Avouac, Jerôme, Flipo, Rene-Marc, Georgin-Lavialle, Sophie, El Mahou, Soumaya, Pertuiset, Edouard, Pham, Thao, Servettaz, Amelie, Marotte, Hubert, Domont, Fanny, Chazerain, Pascal, Devaux, Mathilde, Mekinian, Arsene, Sellam, Jérémie, Fautrel, Bruno, Rouzaud, Diane, Ebstein, Esther, Costedoat-Chalumeau, Nathalie, Richez, Christophe, Hachulla, Eric, Mariette, Xavier, Seror, Raphaèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075312/ https://www.ncbi.nlm.nih.gov/pubmed/37035330 http://dx.doi.org/10.3389/fmed.2023.1152587

Ejemplares similares

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Facteurs associés à la sévérité de l’infection COVID-19 chez les patients atteints de spondyloarthrite : résultats de la French RMD COVID-19 cohorte
por: Perrot, L., et al.
Publicado: (2021)

Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2 : étude de 871 patients()
por: Trefond, Ludovic, et al.
Publicado: (2022)

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
por: Trefond, Ludovic, et al.
Publicado: (2021)

COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases
por: Bourguiba, Rim, et al.
Publicado: (2022)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
por: Delplanque, Marion, et al.
Publicado: (2022)

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.
por: Delplanque, Marion, et al.
Publicado: (2022)

Impact des maladies auto-immunes/auto-inflammatoires rares et de leur traitement sur la sévérité de l’infection à SARS-CoV-2 : à propos de 691 patients de la cohorte française FAI(2)R
por: Georgin-Lavialle, S.
Publicado: (2020)

Impact d’un traitement par hydroxychloroquine comme DMARD sur l’infection à COVID-19 et les tests diagnostiques du SARS-CoV2 : résultats de la cohorte French RMD Covid 19
por: Trefond, L., et al.
Publicado: (2021)

Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nguyen, Yann, et al.
Publicado: (2020)

La prophylaxie pré-exposition par tixagévimab/cilgavimab est efficace pour limiter le risque de contamination et la sévérité de la COVID-19 des patients atteints de maladies auto-immunes ou inflammatoires insuffisamment répondeurs à la vaccination
por: Thomas, M., et al.
Publicado: (2022)

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection
por: Comarmond, Cloé, et al.
Publicado: (2023)

Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study
por: Beydon, Maxime, et al.
Publicado: (2023)

Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database
por: Seror, Raphaele, et al.
Publicado: (2022)

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
por: Corsia, Alice, et al.
Publicado: (2017)

Commentary: First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
por: Costedoat-Chalumeau, Nathalie, et al.
Publicado: (2020)

Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
por: Bermas, Bonnie, et al.
Publicado: (2022)

Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory Diseases
por: Boursier, Guilaine, et al.
Publicado: (2019)

COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study
por: Vieira, Matheus, et al.
Publicado: (2022)

Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study
por: Flipo, René-Marc, et al.
Publicado: (2017)

French Amyloidosis CAPS study: AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 14 cases and review of 53 cases from literature
por: Georgin-Lavialle, S, et al.
Publicado: (2015)

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
por: Bonnet, Isabelle, et al.
Publicado: (2021)

The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review
por: Hentgen, Véronique, et al.
Publicado: (2020)

Assessment of type I interferon response in routine practice in France in 2022
por: Nombel, Anais, et al.
Publicado: (2023)

Intravascular lymphoma presenting as a specific pulmonary embolism and acute respiratory failure: a case report
por: Georgin-Lavialle, Sophie, et al.
Publicado: (2009)

In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis
por: Gorlier, Clémence, et al.
Publicado: (2019)

Response to Letter to the Editor
por: Gorlier, Clémence, et al.
Publicado: (2020)

Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients
por: Davergne, Thomas, et al.
Publicado: (2021)

Association of Vasculitis and Familial Mediterranean Fever
por: Abbara, Salam, et al.
Publicado: (2019)

Tolérance du vaccin anti-COVID-19 chez 190 patients adultes atteints de maladies auto-inflammatoires et inclus dans la JIR Cohorte
por: Bourguiba, R., et al.
Publicado: (2021)

Lymphoma complicating rheumatoid arthritis: results from a French case–control study
por: Kedra, Joanna, et al.
Publicado: (2021)

Reporting of results from network meta-analyses: methodological systematic review
por: Bafeta, Aïda, et al.
Publicado: (2014)

Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review
por: Bafeta, Aïda, et al.
Publicado: (2013)

Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022)

Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis
por: Pacoureau, Lucas, et al.
Publicado: (2023)

Predictive Clinical and Biological Criteria for Gene Panel Positivity in Suspected Inherited Autoinflammatory Diseases: Insights from a Case–Control Study
por: Heiser, Lionel, et al.
Publicado: (2023)

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
por: Bitoun, Samuel, et al.
Publicado: (2022)

La fièvre méditerranéenne familiale est-elle uns situation à risque de développer une forme grave d’infection par la COVID19 ? Résultat d’une étude rétrospective sur 627 patients en période et zone endémique en France
por: Bourguiba, R., et al.
Publicado: (2021)

Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
por: Costedoat-Chalumeau, Nathalie, et al.
Publicado: (2005)

Environment and Lifestyle: Their Influence on the Risk of RA
por: Salliot, Carine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1qa8brcjo07hr9mm5pjlqtd0d2